… with CMV disease without positive surveillance cultures, we elected to try to suppress all
CMV disease by giving ganciclovir to all CMV-… that ganciclovir given prophylactically to CMV-…

… to all transplant patients for the prevention of CMV disease. An optimal strategy will … Ganciclovir
remains an important therapeutic option for the prevention and treatment of CMV disease …

… Pneumocystis carinii pneumonia, disease caused by the … of CMV disease in patients with
AIDS makes prophylaxis against … of oral ganciclovir in the prevention of CMV disease in …

… most important risk factors for CMV disease in our patients. … months of ganciclovir or
valganciclovir prophylaxis was effective … had CMV disease after discontinuing 3 months' …

… prophylaxis controls [54]. These data suggest that valganciclovir and ganciclovir have similar
efficacy in preventing CMV disease and … valganciclovir use in prophylaxis or preemption. …

… Compared with the patients receiving preemptive therapy and prophylaxis with ganciclovir
in a previous meta-analysis (21), the patients receiving valganciclovir in this study had lower …

… a CMV-related wasting syndrome after ganciclovir prophylaxis was … CMV while receiving
prophylactic ganciclovir, and two patients … CMV pneumonia despite uninterrupted ganciclovir …

… after discontinuation of ganciclovir following a negative … early ganciclovir treatment in
preventing early CMV disease in … developed CMV disease) and the discontinuation of ganciclovir …

… infection and disease in CMV … CMV infection and disease by oral ganciclovir prophylaxis
for 3 months after TX. There were no CMV-related deaths among patients with oral ganciclovir …

… infection and disease have shown limited benefit in … of oral ganciclovir in the prevention
of CMV disease following … who developed CMV disease in the ganciclovir prophylaxis group …